Is Rigel Pharmaceuticals (RIGL) 2026 Revenue Guidance Reframing Its Commercial-Led Investment Narrative? [Yahoo! Finance]
Rigel Pharmaceuticals, Inc. (RIGL)
Last rigel pharmaceuticals, inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.rigel.com
Company Research
Source: Yahoo! Finance
million to US$265 million in net product sales and US$20 million to US$25 million in contract revenues. This guidance, paired with earlier strong product and contract revenue performance, highlights how Rigel is leaning on its commercial portfolio to underpin near-term growth expectations. We will now examine how Rigel's newly issued 2026 revenue guidance reshapes its existing investment narrative and future earnings outlook. Find companies with promising cash flow potential yet trading below their fair value To own Rigel Pharmaceuticals, you need to believe its commercial hematology and oncology portfolio can keep funding the business while the pipeline matures, despite product concentration and competition risks. The new 2026 revenue guidance reinforces the role of marketed products as the main short term catalyst, but does not materially change the key risk that earnings are boosted by non cash collaboration items rather than recurring operating cash flow. The 2026 revenu
Show less
Read more
Impact Snapshot
Event Time:
RIGL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RIGL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RIGL alerts
High impacting Rigel Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
RIGL
News
- Rigel Pharmaceuticals (NASDAQ:RIGL) had its "buy" rating reaffirmed by analysts at Citigroup Inc..MarketBeat
- Rigel Provides Business Update and 2026 Outlook [Yahoo! Finance]Yahoo! Finance
- Rigel Provides Business Update and 2026 OutlookPR Newswire
- Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)PR Newswire
- Rigel to Present at the 44th Annual J.P. Morgan Healthcare ConferencePR Newswire
RIGL
Earnings
- 11/4/25 - Beat
RIGL
Sec Filings
- 1/12/26 - Form 8-K
- 12/29/25 - Form 4
- 12/10/25 - Form 8-K
- RIGL's page on the SEC website